Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1960 1
1962 1
1965 1
1972 2
1973 3
1974 1
1975 1
1978 2
1979 2
1980 2
1981 4
1982 2
1983 3
1984 5
1985 1
1986 2
1987 2
1988 4
1989 1
1990 1
1991 1
1992 1
1995 1
1996 5
1997 3
1998 1
1999 2
2002 1
2005 1
2006 4
2010 7
2011 1
2013 1
2014 2
2015 1
2016 2
2017 1
2018 4
2019 3
2021 1
2022 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

87 results

Results by year

Filters applied: . Clear all
Page 1
Herpes Zoster.
Schmader K. Schmader K. Ann Intern Med. 2018 Aug 7;169(3):ITC19-ITC31. doi: 10.7326/AITC201808070. Ann Intern Med. 2018. PMID: 30083718 Review.
Primary care providers and hospitalists frequently encounter older or immunocompromised patients with herpes zoster accompanied by debilitating pain. Atypical presentations and zosteriform herpes simplex may present diagnostic challenges to clinicians. ...Tre …
Primary care providers and hospitalists frequently encounter older or immunocompromised patients with herpes zoster accompanie …
Herpes Zoster.
Goldstein MR, Mascitelli L. Goldstein MR, et al. Ann Intern Med. 2018 Dec 18;169(12):897. doi: 10.7326/L18-0557. Ann Intern Med. 2018. PMID: 30557430 No abstract available.
Herpes Zoster.
Schmader K. Schmader K. Ann Intern Med. 2018 Dec 18;169(12):897. doi: 10.7326/L18-0558. Ann Intern Med. 2018. PMID: 30557431 No abstract available.
Effectiveness of Recombinant Zoster Vaccine Against Herpes Zoster in a Real-World Setting.
Zerbo O, Bartlett J, Fireman B, Lewis N, Goddard K, Dooling K, Duffy J, Glanz J, Naleway A, Donahue JG, Klein NP. Zerbo O, et al. Ann Intern Med. 2024 Feb;177(2):189-195. doi: 10.7326/M23-2023. Epub 2024 Jan 9. Ann Intern Med. 2024. PMID: 38190712
BACKGROUND: A 2-dose series of recombinant zoster vaccine (RZV) was 97% effective against herpes zoster (HZ) in a pivotal clinical trial. ...Vaccine effectiveness was 65% in persons who received corticosteroids before vaccination and 77% in those who did not. …
BACKGROUND: A 2-dose series of recombinant zoster vaccine (RZV) was 97% effective against herpes zoster (HZ) in a pivot …
Recent advances in varicella-zoster virus infection.
Cohen JI, Brunell PA, Straus SE, Krause PR. Cohen JI, et al. Ann Intern Med. 1999 Jun 1;130(11):922-32. doi: 10.7326/0003-4819-130-11-199906010-00017. Ann Intern Med. 1999. PMID: 10375341 Free article. Review.
Acyclovir has been the mainstay for treating severe varicella-zoster virus infections; however, newer antiviral agents, including valacyclovir and famciclovir, have expanded therapeutic options for treating adults with herpes zoster. The recently licensed liv …
Acyclovir has been the mainstay for treating severe varicella-zoster virus infections; however, newer antiviral agents, including val …
The Safety and Immunologic Effectiveness of the Live Varicella-Zoster Vaccine in Patients Receiving Tumor Necrosis Factor Inhibitor Therapy : A Randomized Controlled Trial.
Curtis JR, Cofield SS, Bridges SL Jr, Bassler J, Deodhar A, Ford TL, Huffstutter J, Jankeel A, Kivitz A, Kamal S, Lindsey S, Messaoudi I, Mendoza N, Michaud K, Mikuls TR, Ridley D, Shergy W, Siegel SAR, Winthrop KL. Curtis JR, et al. Ann Intern Med. 2021 Nov;174(11):1510-1518. doi: 10.7326/M20-6928. Epub 2021 Sep 28. Ann Intern Med. 2021. PMID: 34570596 Clinical Trial.
OBJECTIVE: To evaluate the safety and immunogenicity of the live attenuated zoster vaccine (ZVL) in patients receiving TNFis. DESIGN: Randomized, blinded, placebo-controlled trial. ...MEASUREMENTS: Glycoprotein enzyme-linked immunosorbent assay (gpELISA) and enzyme-linked …
OBJECTIVE: To evaluate the safety and immunogenicity of the live attenuated zoster vaccine (ZVL) in patients receiving TNFis. DESIGN: …
In the clinic. Herpes zoster.
Wilson JF. Wilson JF. Ann Intern Med. 2011 Mar 1;154(5):ITC31-15; quiz ITC316. doi: 10.7326/0003-4819-154-5-201103010-01003. Ann Intern Med. 2011. PMID: 21357905 Review.
This issue provides a clinical overview of herpes zoster focusing on prevention, diagnosis, treatment, practice improvement, and patient information. ...
This issue provides a clinical overview of herpes zoster focusing on prevention, diagnosis, treatment, practice improvement, a …
Drugs five years later: acyclovir.
Dorsky DI, Crumpacker CS. Dorsky DI, et al. Ann Intern Med. 1987 Dec;107(6):859-74. doi: 10.7326/0003-4819-107-6-859. Ann Intern Med. 1987. PMID: 3318610 Review.
In the 5 years since its release for clinical use, acyclovir (9-[2-hydroxyethoxymethyl]guanine) has proved to be a safe and effective agent for therapy of herpes simplex and varicella-zoster infections. The drug's availability in topical, oral, and intravenous prepa …
In the 5 years since its release for clinical use, acyclovir (9-[2-hydroxyethoxymethyl]guanine) has proved to be a safe and effective agent …
87 results